Federal prosecutors have assembled a recognizable pattern for genetic testing fraud cases that reach into Medicare, and physicians sit inside that pattern more often than they realize. The government's September 2019 enforcement action targeting genetic testing fraud, announced jointly by the Department of Justice and the HHS Office of Inspector General, charged 35 defendants with more than $2.1 billion in fraudulent claims, including physicians who signed off on tests in exchange for kickbacks. The same pattern recurs in 2026: a January guilty plea tied to more than $52 million in claims, and a May sentencing tied to $522 million billed to Medicare, Medicaid, and private insurers. Each case traces the same three links: a telemarketing operation that reaches the beneficiary, a physician order that reaches the laboratory, and a laboratory claim that reaches Medicare.
The Telemarketing Pipeline That Starts the Claim
The scheme's first link is built to look incidental. Telemarketers reach Medicare beneficiaries through phone calls, booths at health fairs, and door-to-door visits, offering a free cheek swab or screening kit, a pattern the HHS Office of Inspector General described directly in its fraud alert on genetic testing scams. In the laboratory case sentenced in May 2026, marketers obtained DNA samples through telemarketing, door-to-door solicitation, and health fair appearances, then used the beneficiary's Medicare number to support a lab claim the beneficiary never requested from a treating physician. This recruitment layer falls within our healthcare fraud defense practice, and the beneficiary's consent to a swab is not consent to the billing that follows.
Physician Orders Without a Treatment Relationship
The order is the link prosecutors build the case around, because Medicare requires one from a treating physician before it pays a genetic testing claim. The January 2026 guilty plea described how that requirement gets manufactured: recruiters faxed physicians false and misleading prescription requests, drafted to look like they came from an existing patient relationship, to trick the physician into signing off on tests the patient did not need. A physician who signs a requisition for a patient never examined, generated through a telemarketing or lead-generation channel, has stepped into anti-kickback statute exposure, and, where the physician holds a financial relationship with the lab, stark law exposure as well. Liability under the Anti-Kickback Statute turns on what the physician knowingly and willfully did, not on an honest scheduling or documentation mistake, which is why the safeguards described in Building an Effective Compliance Program That Counts matter before the fax arrives, not after.
How Laboratory Billing Closes the Loop
Neither the telemarketing lead nor the signed order produces a dollar of exposure until the laboratory files the claim. In the May 2026 sentencing, the laboratories had billed approximately $522 million in false and fraudulent claims, of which Medicare, Medicaid, and private insurers paid approximately $84 million, built on requisition forms from providers who had not treated or consulted with the beneficiaries and did not use the results in treatment. The two defendants were sentenced to 151 months and three years in prison. That gap between the amount billed and the amount paid shows a lab billing far beyond what the referral pattern can plausibly support. The line between an isolated billing error and a built fraud scheme is a real one, addressed in Billing Error or Fraud: Where Enforcement Draws the Line, and it is the line that decides whether a case against the ordering physician holds together.
The physician's order is the one document that turns a telemarketing lead into a Medicare claim, which is exactly why prosecutors build the case around it.
Why Early Legal Counsel Is Critical
It is critical that physicians promptly retain experienced healthcare defense counsel upon receiving a grand jury subpoena, a civil investigative demand, or any other government inquiry tied to genetic testing orders. Early legal intervention can protect the physician's rights, guide appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the physician's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the physician to unnecessary risk.
For what a civil investigative demand actually requires in response, see Responding to a Civil Investigative Demand (CID).
How Health Law Alliance Can Help
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience. If you ordered, signed, or are named in connection with genetic testing claims traced to a telemarketing referral, contact us for a free, confidential consultation through our criminal healthcare fraud defense practice before responding to any government inquiry.
